$13.07
+0.20 (+1.55%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+172.0% upside
Low Target
$27.68
Average Target
$35.55
High Target
$47.36
Current Price
$13.07
Current
$13.07
$13.07
Target
$35.55
$35.55
$27.68
$35.55 avg
$47.36
Scenario Analysis
Bear Case
$27.68
111.8%
Low target
Base Case
$35.55
+172.0%
Avg target
Bull Case
$47.36
+262.4%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$16.33
-20.0% from high
52-Week Low
$1.50
+771.3% from low
Target vs 52W High
$35.55
+117.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.6% |
| AMGN | Hold | 43 | 47% | $190.87 | -51.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +140.9% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.2% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -13.6% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -61.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |